+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Norway - Healthcare, Regulatory and Reimbursement Landscape

  • PDF Icon

    Report

  • 150 Pages
  • May 2021
  • Region: Norway
  • GlobalData
  • ID: 5323704
Description Jump to:
This report is an essential source of information on analysis of healthcare, regulatory, and reimbursement landscape in Norway. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.

The Norway pharmaceutical market was worth3.29 in 2013, which decreased to3.26B in 2019 at a negative CAGR of 0.13%. The market value is expected to decrease further to3.23B by 2025. Norway is a well-developed healthcare market in Northern Europe with the patient-centered approach towards care and treatment, data-driven innovation, and universal health coverage. In January 2016, the Norwegian Directorate of eHealth (NDE) was established to implement several national eHealth policies and encourage the adoption of digital health solutions.

Norway’s robust healthcare system, increasing elderly population, increased prevalence of chronic diseases, and growing pharmaceutical consumption are attributed to the growth of the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Norway, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, Sanofi, GSK, and Navamedic
  • Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Roche, Alcon, and Photocure
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, healthtech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Norway healthcare market

Reasons to Buy this Report

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving Norway’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Norway’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1. Table of Contents
1.1 List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights: Facts about the Norway Healthcare Market
2.3 Key Highlights: Healthcare Startups in Norway
2.4 Key Events: Norway Healthcare Timeline, 2015-2021
2.5 Key Events: Norway Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Top Completed Deals by Value, 2019-2020
2.8 Country Profile, Norway, 2020
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Norway
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Norway
3.7 COVID-19 Epidemiology, Norway
3.8 COVID-19 Impact and Developments in the Healthcare Market, Norway
3.9 COVID-19 Clinical Trials Landscape, Norway
3.10 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Norway, 2019-2021
6.2 Deal Analysis: Medical Device Market, Norway, 2019-2021
7. HealthTech Landscape
7.1HealthTech Deals Landscape, Norway
7.2 HealthTech Ecosystem, Norway
7.3 Adoption of Technology in Healthcare, Norway
7.4 Key HealthTech Deals, Norway
7.5 Government-Sponsored Schemes Promoting Startups, Norway
7.6 Regulatory Scenario Covering Use of Technology in Healthcare, Norway
7.7 HealthTech Landscape: Benefits and Risks, Norway
8. Market Access
8.1 Overview of Healthcare System, Norway
8.2 Reimbursement Process, Norway
8.3 Overview of Insurance Providers, Norway
8.4 Healthcare Spending and Medicine Price Index, Norway
8.5 Pricing Policies, Norway
8.6 Regulatory Landscape, Norway
8.6.1 Marketing Authorization for Pharmaceutical Products, EU
8.6.2 Marketing Authorization for Pharmaceutical Products, Norway
8.6.3 Market Authorization for Medical Devices, Norway
8.6.4 Imports, Norway
8.6.5 Intellectual Property Rights, Patent, Norway
8.6.6 Intellectual Property Rights, European Patent, Norway
8.6.7 Intellectual Property Rights, Trademarks, Norway
8.6.8 Clinical Trial Regulation Process, Norway
8.6.9 Pharmaceutical Clinical Trials Landscape, Norway
8.6.10 Medical Devices Clinical Trials Landscape, Norway
8.6.11 Pharmaceutical Advertisement Regulations, Norway
8.6.12 Pharmacy Regulations, Norway
8.6.13 Labeling and Packaging Regulations, Norway
9. Country Healthcare Landscape
9.1 Healthcare Policy Highlights
9.2 Healthcare Facilities, Norway
9.3 Healthcare Parameters, Norway
9.4 Life Expectancy and Immunization Rate, Norway
9.5 Environmental Health, Norway
9.6 Healthcare Personnel, Norway
9.7 Disease Burden, Norway
9.8 Healthcare Expenditure, Norway
9.9 Healthcare Spending Components and Pharmaceutical Spending, Norway
10. Trade Associations, Norway11. Trade Fairs, Norway12. Opportunities and Challenges
13. Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About
13.4 Contact
13.5 Disclaimer
List of Tables
Table 1: Pharmaceutical Market, Norway, Sales of Patented Drug Products by Major Therapeutic Class ($M), 2019
Table 2: COVID-19 Indicators (Number of Cases), Global and Norway, 2021
Table 3: COVID-19-Related Travel Restrictions, Norway, 2020-2021
Table 4: COVID-19 In Vitro Diagnostics Products, Norway, 2021
Table 5: Medical Device Market, Norway, Major Segments ($M), 2020
Table 6: Orthopedic Devices Market, Norway, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 7: Cardiovascular Devices Market, Norway, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 8: General Surgery Market, Norway, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 9: Wound Care Management Market, Norway, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 10: In Vitro Diagnostics Market, Norway, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 11:Reimbursement Categories and Rates, Norway, 2020
Table 12: Reimbursement Prescription Schemes, Norway, 2020
Table 13: National Insurance Contribution Rates, Norway, 2020
Table 14: Pricing Procedures, Norway, 2020
Table 15: Marketing Authorization Application Fee (National Procedure) for Human Use , Norway, 2021
Table 16: Types of Import Authorizations for Clinical Studies, Norway, 2020
Table 17: Patent Fees, Norway, 2020
Table 18: Trademark Fees, Norway, 2020
Table 19: Clinical Trial Regulation, Norway, 2020
Table 20: Advertising Regulations, Norway, 2020
Table 21: Labelling And Package Leaflet Regulations, Norway, 2020
Table 22: Nordic Package Regulation, 2020
List of Figures
Figure 1: Pharmaceutical Market, Norway, Revenue ($B), 2013-2019
Figure 2: Medical Device Market, Norway, Revenue ($B), 2015-2020
Figure 3: Healthcare Startups in Norway, 2020
Figure 4: Number of Deals (2019-2020)
Figure 5: 2019-2020 Deal Overview by Region
Figure 6: Country Profile, Norway, 2020
Figure 7: Pharmaceutical Market, Norway, Revenue ($B), 2013-2019
Figure 8: Pharmaceutical Market, Norway, Revenue Forecast ($B), 2020-2025
Figure 9: Pharmaceutical Exports ($B), Norway, 2013-2020
Figure 10: Top Export Partners, Norway, 2020
Figure 11: Pharmaceutical Imports ($B), Norway, 2013-2020
Figure 12: Top Import Partners, Norway, 2020
Figure 13: Pharmaceutical Supply Channel, Norway, 2020
Figure 14: Generic Drugs Usage (% Share by Volume), Norway, 2012-2018
Figure 15: Generic Drugs Usage (% Share by Value), Norway, 2012-2018
Figure 16: OTC Market, Norway, Revenue ($B), 2012-2020
Figure 17: OTC Medicines Market, Major Categories ($M), Norway, 2020
Figure 18: OTC Medicines Market, Major Distribution Channels ($M), Norway, 2020
Figure 19: Pharmaceutical Market, Norway, Sales of Patented Drug Products by Major Therapeutic Class, 2019
Figure 20: COVID-19 (Cases), Norway, 2020-2021
Figure 21: COVID-19 (Deaths), Norway, 2020-2021
Figure 22: COVID-19 Fiscal Stimulus Timeline, Norway, 2020-2021
Figure 23: Cumulative Number of COVID-19 Vaccine Doses Administered, Norway, 2021
Figure 24: COVID-19 Clinical Trials Count By Trial Status, Norway, 2020-2021
Figure 25: COVID-19 Clinical Trials Count By Phase, Norway, 2020-2021
Figure 26: Top Five COVID-19 Clinical Trials Sponsors By Count, Norway, 2020-2021
Figure 27: Medical Device Market, Norway, Revenue ($B), 2015-2020
Figure 28: Medical Device Market, Norway, Revenue Forecast ($B), 2021-2025
Figure 29: Medical Device Market, Norway, Major Segments (%), 2020
Figure 30: General Surgery Market, Norway, Revenue ($M), 2017-2025
Figure 31: General Surgery Market, Norway, Market Share of Major Players (%), 2019
Figure 32: Orthopedic Devices Market, Norway, Revenue ($M), 2017-2025
Figure 33: Orthopedic Devices Market, Norway, Market Share of Major Players (%), 2019
Figure 34: Wound Care Management Market, Norway, Revenue ($M), 2017-2025
Figure 35: Wound Care Management Market, Norway, Market Share of Major Players (%), 2019
Figure 36: Cardiovascular Devices Market, Norway, Revenue ($M), 2017-2025
Figure 37: Cardiovascular Devices Market, Norway, Market Share of Major Players (%), 2019
Figure 38: In Vitro Diagnostics Market, Norway, Revenue ($M), 2017-2025
Figure 39: In Vitro Diagnostics Market, Norway, Market Share of Major Players (%), 2018
Figure 40: Diagnostics Market, Norway, Revenue ($M), 2015-2020
Figure 41: Diagnostics Market, Norway, Revenue ($M), 2021-2025
Figure 42: Medical Devices Market, Revenue ($B) of Major Companies, Norway, 2019
Figure 43: Deal Value and Deal Count, Pharmaceutical Market, Norway, 2019-2021
Figure 44: Deal Value and Deal Count Subtypes, Pharmaceutical Market, Norway, 2019-2021
Figure 45: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Norway, 2019-2021
Figure 46: Top Therapy Areas by Deal Value, Pharmaceutical Market, Norway, 2019-2021
Figure 47: Top Therapy Areas by Deal Count, Pharmaceutical Market, Norway, 2019-2021
Figure 48: Mergers and Acquisitions Deals by Quarter, Pharmaceutical Market, Norway, 2019-2021 (by Value and by Number)
Figure 49: Venture Financing Deals by Quarter, Pharmaceutical Market, Norway, 2019-2021 (by Value and by Number)
Figure 50: Deal Value and Deal Count, Medical Devices Market, Norway, 2019-2021
Figure 51: Deal Value and Deal Count, Quarterly, Medical Devices Market, Norway, 2019-2021
Figure 52: Deal Value and Deal Count Subtypes, Medical Devices Market, Norway, 2019-2021
Figure 53: Top Equipment Sectors by Deal Value, Medical Devices Market, Norway, 2019-2021
Figure 54: Top Equipment Sectors by Deal Count, Medical Devices Market, Norway, 2019-2021
Figure 55: Venture Financing Deals by Equipment Sector, Medical Devices Market, Norway, 2019-2021 (by Value and by Number)
Figure 56: Deal Value ($M), HealthTech, Norway, 2019-2021
Figure 57: Deal Count ($M), HealthTech, Norway, 2019-2021
Figure 58: HealthTech Ecosystem, 2020
Figure 59: Organization of the Health System, Norway, 2020
Figure 60: Decision Making Process, Norway, 2020
Figure 61: OOP Expenditure (% of Total Expenditure on Health), Norway, 2012-2019
Figure 62: Annual Rate of Change (%), Health Price Index, Norway, 2013-2019

Related Topics

Related Reports

Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 275 Pages
  • Global
From
Global Behavioral Health Market by Disorder (Anxiety & Depression, Autism, Bipolar Disorders), Component (Services, Software), Treatment, Age Group, End-User - Forecast 2024-2030 - Product Image

Global Behavioral Health Market by Disorder (Anxiety & Depression, Autism, Bipolar Disorders), Component (Services, Software), Treatment, Age Group, End-User - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Global Healthcare Reimbursement Market by Claim (Fully Paid, Underpaid), Payer (Private Payers, Public Payers), Service Provider - Forecast 2024-2030 - Product Image

Global Healthcare Reimbursement Market by Claim (Fully Paid, Underpaid), Payer (Private Payers, Public Payers), Service Provider - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Global Medical Billing Outsourcing Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Medical Billing Outsourcing Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 173 Pages
  • Global
From
Global Revenue Cycle Management Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis - Product Image

Global Revenue Cycle Management Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.